IGC Pharma, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $538.0K | $1.5M | $824.5K | $1.0M | $1.1M | $562.9K | $1.6M |
| Accounts Receivable | $752.9K | $962.7K | $993.3K | $566.3K | $1.1M | $1.6M | $3.3M |
| Inventory | $0 | $162.1K | $709.6K | $611.7K | $407.1K | $387.5K | $133.5K |
| Total Current Assets | $3.6M | $3.8M | $4.5M | $3.8M | $4.3M | $5.2M | $6.5M |
| Property, Plant & Equipment | $953.9K | $7.1M | $7.8M | $7.6M | $8.2M | $8.5M | $1.2M |
| Goodwill | $198.2K | $1.2M | $982.8K | $0 | $0 | $965.7K | $410.5K |
| Intangible Assets (Excl. Goodwill) | $0 | $113.3K | $306.1K | $468.1K | $592.3K | $3.8M | — |
| Total Assets | $11.3M | $18.9M | $20.3M | $17.7M | $19.3M | $25.3M | $18.2M |
| Liabilities | |||||||
| Accounts Payable | $416.5K | $330.6K | $174.6K | $133.4K | $600.7K | $337.1K | $1.3M |
| Total Current Liabilities | $1.3M | $3.2M | $2.4M | $1.0M | $1.8M | $4.5M | $6.6M |
| Long-Term Debt | $452.1K | $801.5K | $323.9K | $0 | — | — | — |
| Total Liabilities | $3.9M | $4.9M | $5.6M | $3.6M | $4.3M | $9.4M | $7.8M |
| Stockholders' Equity | |||||||
| Retained Earnings | $-52.0M | $-50.1M | $-47.3M | $-42.7M | $-39.7M | $-37.4M | $-29.7M |
| Total Stockholders' Equity | $7.4M | $13.5M | $14.2M | $13.6M | $14.4M | $14.8M | $6.7M |